Reasonably lackluster trading for the past week or so. Punters waiting for the QRTLY and details of sales. Bottom line (financials) should be consistent with the previous QTR based on Hologic payment in late June. Receipts for individual product sales will be interesting given the warmer months in Europe and the U.S and the recent generalized comments from management regarding sales of FebriDx & ViraDx. Watching closely. DYOR.
Ann: Lumos Expands Henry Schein FebriDx Distribution Partnership, page-53
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LDX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.3¢ |
Change
-0.001(2.27%) |
Mkt cap ! $20.69M | |||
| Open | High | Low | Value | Volume |
| 4.4¢ | 4.4¢ | 4.3¢ | $58.21K | 1.335M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 200000 | 4.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.5¢ | 535000 | 4 |
View Market Depth
| Last trade - 15.29pm 16/07/2024 (20 minute delay) ? |
| LDX (ASX) Chart |